Agenus | AGEN - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
AbbVie USD 14.39B 1.85B 2026-06
Agenus USD 33.74M 468K 2026-03
Amgen USD 5.87B 1.02B 2026-03
AstraZeneca USD 12.86B 251M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Celldex Therapeutics USD 15K 106K 2026-03
CSL USD 4.46B 2.71B 2025-12
Eli Lilly USD 16.22B 301.7M 2026-03
Gilead Sciences USD 6.8B 1.29B 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
Glaxosmithkline GBP 5.75B 2.99B 2026-03
Incyte USD 1.57B 400.89M 2026-06
Intrexon USD -297K 167K 2024-06
J&J USD 18.55B 1.31B 2026-06
Jiangsu Hengrui CNY 7.05B 224.5M 2026-03
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
MacroGenics USD 11.24M 19.87M 2026-03
Merck EUR 3.17B 101M 2026-06
Merck USD 12.09B 1.24B 2026-03
Novartis USD 11.24B 1.18B 2026-06
Novavax USD 125.04M 76.09M 2025-12
Pfizer USD -248M 11.29B 2026-06
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Veracyte USD 108.55M 7.39M 2026-06